Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 10.15 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cybin Inc < Previous 1 2 ... 9 10 11 12 13 14 15 16 17 ... 38 39 Next > The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week February 06, 2023 Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023. Via Talk Markets Mind Medicine, GH Research Among Top Psychedelic Movers Of Today February 06, 2023 Via Benzinga The 7 Most Promising Psychedelic Stocks to Buy in February February 05, 2023 These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. Via InvestorPlace 6 Largest Psychedelic Stocks Down 3% This Week February 04, 2023 The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... Via Talk Markets Psychedelic Stock Gainers And Losers From February 3, 2023 February 03, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 2, 2023 February 02, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 1, 2023 February 01, 2023 Via Benzinga PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Approval for First-in-Human Dosing of Proprietary DMT Molecule February 01, 2023 Via Investor Brand Network Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment February 01, 2023 Cybin Inc. (NYSE: CYBN) announced that it has received approval from an independent ethics committee in the Netherlands to begin the first in-human dosing of its proprietary deuterated... Via Benzinga Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004 February 01, 2023 From Cybin Inc. Via Business Wire GH Research, Mind Medicine Among Top Psychedelic Movers Of Today January 31, 2023 Via Benzinga Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today January 30, 2023 Via Benzinga The "Multi-Bagger" Portfolio Update: Week Ending January 27 January 29, 2023 Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but many of them could possibly bounce back with major returns in 2023. We track the performance of a basket of 10 such... Via Talk Markets Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD January 28, 2023 We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. Via Talk Markets Cybin, GH Research Among Top Psychedelic Movers Of Today January 27, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 26, 2023 January 26, 2023 Via Benzinga PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Virtual R&D Day January 26, 2023 Via Investor Brand Network Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry January 26, 2023 EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END Via FinancialNewsMedia Topics Economy Exposures Supply Chain Cybin to Host Virtual R&D Day on February 28, 2023 January 26, 2023 From Cybin Inc. Via Business Wire Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today January 25, 2023 Via Benzinga Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More January 25, 2023 Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? Via Benzinga Psychedelic Stock Gainers And Losers From January 24, 2023 January 24, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 23, 2023 January 23, 2023 Via Benzinga Largest Psychedelic Stocks +3% This Week; Now +15% YTD January 21, 2023 Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... Via Talk Markets Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today January 20, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 19, 2023 January 19, 2023 Via Benzinga Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today January 18, 2023 Via Benzinga Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain January 18, 2023 Cybin Inc. Via Benzinga PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study January 18, 2023 Via Investor Brand Network Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain January 18, 2023 From Cybin Inc. Via Business Wire < Previous 1 2 ... 9 10 11 12 13 14 15 16 17 ... 38 39 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
